Desq Long
Sign in

Company

MapLight Therapeutics, Inc.

MPLT · CIK 0001770069

SEC FORM 4
$595,423.28

MapLight Therapeutics, Inc. (MPLT)

Sale of 73,691 shares at $8.08 per share.

Reporting Person Kroeger Christopher A. · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001658918-26-000018 · filed 2026-10-16 · View filing →

SEC FORM 4
$82,149.36

MapLight Therapeutics, Inc. (MPLT)

Sale of 10,167 shares at $8.08 per share.

Reporting Person GILLIS JONATHAN · Officer Title CAO and Interim CFO · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001709954-26-000014 · filed 2026-10-16 · View filing →

SEC FORM 4
$93,025.04

MapLight Therapeutics, Inc. (MPLT)

Sale of 11,513 shares at $8.08 per share.

Reporting Person Lillie James Woodruff · Officer Title Chief Scientific Officer · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001728746-26-000018 · filed 2026-10-16 · View filing →

SEC FORM 4
$72,881.60

MapLight Therapeutics, Inc. (MPLT)

Sale of 9,020 shares at $8.08 per share.

Reporting Person Hanson Kristopher · Officer Title General Counsel · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0001789970-26-000018 · filed 2026-10-16 · View filing →

SEC FORM 4
$124,068.40

MapLight Therapeutics, Inc. (MPLT)

Sale of 15,355 shares at $8.08 per share.

Reporting Person Foff Erin Pennock · Officer Title Chief Medical Officer · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0002021233-26-000016 · filed 2026-10-16 · View filing →

SEC FORM 4
$96,024.32

MapLight Therapeutics, Inc. (MPLT)

Sale of 12,248 shares at $7.84 per share.

Reporting Person Kreitzer Anatol · Officer Title Chief Discovery Officer · Transaction Code S

Traded Oct 15, 2026 · Disclosed Oct 16, 2026

Source: SEC Form 4 · 0002021238-26-000014 · filed 2026-10-16 · View filing →

SEC FORM 4
$192,660.03

MapLight Therapeutics, Inc. (MPLT)

Sale of 16,509 shares at $11.67 per share.

Reporting Person Hanson Kristopher · Officer Title General Counsel · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001789970-26-000016 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 23,145 shares at $0 per share.

Reporting Person Kroeger Christopher A. · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001658918-26-000016 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 6,020 shares at $0 per share.

Reporting Person GILLIS JONATHAN · Officer Title CAO and Interim CFO · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001709954-26-000012 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 2,222 shares at $0 per share.

Reporting Person GILLIS JONATHAN · Officer Title CAO and Interim CFO · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001709954-26-000012 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 7,730 shares at $0 per share.

Reporting Person Lillie James Woodruff · Officer Title Chief Scientific Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001728746-26-000016 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 7,730 shares at $0 per share.

Reporting Person Hanson Kristopher · Officer Title General Counsel · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001789970-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 13,360 shares at $0 per share.

Reporting Person Foff Erin Pennock · Officer Title Chief Medical Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0002021233-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 6,020 shares at $0 per share.

Reporting Person Kreitzer Anatol · Officer Title Chief Discovery Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0002021238-26-000012 · filed 2026-08-19 · View filing →